廣告
香港股市 將在 6 小時 33 分鐘 開市

  • 恒指

    19,073.71
    -41.35 (-0.22%)
     

  • 國指

    6,741.41
    -20.23 (-0.30%)
     

  • 上證綜指

    3,119.90
    -25.87 (-0.82%)
     

  • 道指

    39,828.21
    +270.10 (+0.68%)
     

  • 標普 500

    5,299.67
    +52.99 (+1.01%)
     

  • 納指

    16,725.65
    +214.47 (+1.30%)
     

  • Vix指數

    12.70
    -0.72 (-5.37%)
     

  • 富時100

    8,445.80
    +17.67 (+0.21%)
     

  • 紐約期油

    78.70
    +0.68 (+0.87%)
     

  • 金價

    2,390.80
    +30.90 (+1.31%)
     

  • 美元

    7.8096
    -0.0023 (-0.03%)
     

  • 人民幣

    0.9239
    -0.0015 (-0.16%)
     

  • 日圓

    0.0501
    +0.0005 (+0.91%)
     

  • 歐元

    8.4938
    +0.0450 (+0.53%)
     

  • Bitcoin

    65,341.63
    +3,966.22 (+6.46%)
     

  • CMC Crypto 200

    1,380.92
    +112.98 (+8.92%)
     

Stepan Co. (SCL) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates

Zacks Equity Research
·2 分鐘文章

For the quarter ended March 2024, Stepan Co. (SCL) reported revenue of $551.42 million, down 15.4% over the same period last year. EPS came in at $0.64, compared to $0.71 in the year-ago quarter.

The reported revenue represents a surprise of -4.24% over the Zacks Consensus Estimate of $575.83 million. With the consensus EPS estimate being $0.35, the EPS surprise was +82.86%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

廣告

Here is how Stepan Co. performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Net Sales- Specialty products: $15.09 million versus $19.65 million estimated by two analysts on average.

  • Net Sales- Polymers: $145.51 million compared to the $160.50 million average estimate based on two analysts. The reported number represents a change of -9.7% year over year.

  • Net Sales- Surfactants: $390.82 million versus $402.60 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -16.5% change.

  • Operating income- Surfactants: $26.08 million versus the two-analyst average estimate of $20.45 million.

  • Operating income- Specialty Products: $4.27 million compared to the $3.50 million average estimate based on two analysts.

  • Operating income- Polymers: $8.38 million versus $11.55 million estimated by two analysts on average.

View all Key Company Metrics for Stepan Co. here>>>

Shares of Stepan Co. have returned -4.4% over the past month versus the Zacks S&P 500 composite's -2.5% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Stepan Company (SCL) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research